Literature DB >> 18621448

Synthesis, characterization and antidiabetic properties of N(1)-2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV).

Refiye Yanardag1, Tulay Bal Demirci, Bahri Ulküseven, Sema Bolkent, Sevim Tunali, Sehnaz Bolkent.   

Abstract

A new oxovanadium(IV) chelate [VOL] (L: N(1)-2,4-dihydroxybenzylidene-N(4)-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato) was synthesized and characterized by elemental analysis, conductivity and magnetic measurements, UV-vis, IR, EPR spectroscopy and mass spectrometry. The biochemical and immunohistochemical effects of the administration of the vanadium complex (VOL) into the pancreas of normal and streptozotocin-induced diabetic rats were profoundly investigated. The animals were randomly divided into four groups. Group I: control (intact) animals. Group II: control animals administered with VOL. Group III: STZ-induced diabetic animals. Group IV: STZ-induced diabetic animals administered with VOL. VOL was given to some of the experimental animals by gavage at a dose of 0.2mM/kg every day for 12 days. Blood samples were collected from animals, on 0 and 1, 6 and 12 days after STZ injection. On day 12, the pancreatic tissues were taken from the animals. The tissue sections were labelled with streptavidin biotin peroxidase technique for insulin. In the diabetic group, the blood glucose levels, aspartate and alanine transaminases, alkaline phosphatase activities were increased. But, in the diabetic+VOL groups, the blood glucose levels, aspartate and alanine transaminases, alkaline phosphatase activities were reduced. In the diabetic group, a decrease in the pancreatic glutathione levels, glutathione peroxidase and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed. The administration of VOL to the diabetic rats reversed this diabetic effect due to its insulinomimetic effects. According to the immunohistochemical and biochemical results obtained, it was concluded that VOL can regenerate B cells of the pancreas in experimental diabetes and has an antidiabetic and protective effects on the pancreas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18621448     DOI: 10.1016/j.ejmech.2008.04.023

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  Protective Effects of an Oxovanadium(IV) Complex with N2O2 Chelating Thiosemicarbazone on Small Intestine Injury of STZ-Diabetic Rats.

Authors:  Sevim Tunali; Selda Gezginci-Oktayoglu; Sehnaz Bolkent; Ediz Coskun; Tulay Bal-Demirci; Bahri Ulkuseven; Refiye Yanardag
Journal:  Biol Trace Elem Res       Date:  2020-07-09       Impact factor: 3.738

2.  Decreasing the diabetic complication by vanadyl(VO)2+/vitamin B 6 complex in alloxan-induced diabetic mice.

Authors:  Nahla S El-Shenawy; Moamen S Refat; Fatima H Fakihi
Journal:  J Mater Sci Mater Med       Date:  2013-02-09       Impact factor: 3.896

3.  Does the relief of glucose toxicity act as a mediator in proliferative actions of vanadium on pancreatic islet beta cells in streptozocin diabetic rats?

Authors:  Leila Pirmoradi; Mohammad Taghi Mohammadi; Akbar Safaei; Fakhardin Mesbah; Gholam Abbas Dehghani
Journal:  Iran Biomed J       Date:  2014-07

4.  Oxovanadium(IV) and Nickel(II) complexes obtained from 2,2'-dihydroxybenzophenone-S-methyl-thiosemicarbazone: Synthesis, characterization, electrochemistry, and antioxidant capability.

Authors:  Berat İlhan-Ceylan
Journal:  Inorganica Chim Acta       Date:  2020-12-09       Impact factor: 2.545

5.  Bis-pharmacophore of cinnamaldehyde-clubbed thiosemicarbazones as potent carbonic anhydrase-II inhibitors.

Authors:  Asif Rasool; Zahra Batool; Majid Khan; Sobia Ahsan Halim; Zahid Shafiq; Ahmed Temirak; Mohamed A Salem; Tarik E Ali; Ajmal Khan; Ahmed Al-Harrasi
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.